These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27262306)

  • 1. The Amazing World of Peptide Engineering: the Example of Antimicrobial Peptides from Frogs and Their Analogues.
    Guimarães AB; Costa FJ; Pires OR; Fontes W; Castro MS
    Protein Pept Lett; 2016; 23(8):722-37. PubMed ID: 27262306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial peptide action on parasites.
    Torrent M; Pulido D; Rivas L; Andreu D
    Curr Drug Targets; 2012 Aug; 13(9):1138-47. PubMed ID: 22664071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria.
    Scarim CB; Jornada DH; Machado MGM; Ferreira CMR; Dos Santos JL; Chung MC
    Eur J Med Chem; 2019 Jan; 162():378-395. PubMed ID: 30453246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (975):v-xii, 1-100. PubMed ID: 23484340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome as a Drug Target in Trypanosomatid Diseases.
    Silva ML; de Santiago-Silva KM; Fabris M; Camargo PG; de Lima Ferreira Bispo M
    Curr Drug Targets; 2023; 24(10):781-789. PubMed ID: 37469152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.
    Khare S; Nagle AS; Biggart A; Lai YH; Liang F; Davis LC; Barnes SW; Mathison CJ; Myburgh E; Gao MY; Gillespie JR; Liu X; Tan JL; Stinson M; Rivera IC; Ballard J; Yeh V; Groessl T; Federe G; Koh HX; Venable JD; Bursulaya B; Shapiro M; Mishra PK; Spraggon G; Brock A; Mottram JC; Buckner FS; Rao SP; Wen BG; Walker JR; Tuntland T; Molteni V; Glynne RJ; Supek F
    Nature; 2016 Sep; 537(7619):229-233. PubMed ID: 27501246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosomatid parasites causing neglected diseases.
    Nussbaum K; Honek J; Cadmus CM; Efferth T
    Curr Med Chem; 2010; 17(15):1594-617. PubMed ID: 20166934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
    Heby O; Persson L; Rentala M
    Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Occurrence in Venomous Arthropods of Antimicrobial Peptides Active against Protozoan Parasites.
    Sabiá Júnior EF; Menezes LFS; de Araújo IFS; Schwartz EF
    Toxins (Basel); 2019 Sep; 11(10):. PubMed ID: 31557900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Peptides (AMPs): Potential Therapeutic Strategy against Trypanosomiases?
    Rojas-Pirela M; Kemmerling U; Quiñones W; Michels PAM; Rojas V
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkaloids with antiprotozoal activity.
    Osorio EJ; Robledo SM; Bastida J
    Alkaloids Chem Biol; 2008; 66():113-90. PubMed ID: 19025098
    [No Abstract]   [Full Text] [Related]  

  • 14. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 15. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
    Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
    Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemotherapy of protozoal infections of man.
    Steck EA
    J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
    [No Abstract]   [Full Text] [Related]  

  • 17. Cationic antimicrobial peptide killing of African trypanosomes and Sodalis glossinidius, a bacterial symbiont of the insect vector of sleeping sickness.
    Haines LR; Hancock RE; Pearson TW
    Vector Borne Zoonotic Dis; 2003; 3(4):175-86. PubMed ID: 14733670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
    Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
    Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
    Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
    PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases.
    Nascimento IJDS; Cavalcanti MAT; de Moura RO
    Eur J Med Chem; 2023 Oct; 258():115550. PubMed ID: 37336067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.